scholarly article | Q13442814 |
P50 | author | Leendert A Trouw | Q40406948 |
Rene E Toes | Q42494390 | ||
Hans Ulrich Scherer | Q42663741 | ||
Manfred Wuhrer | Q45905459 | ||
Gerd-Rüdiger Burmester | Q47261275 | ||
Andreea Ioan-Facsinay | Q47657307 | ||
Diane van der Woude | Q55314080 | ||
Tom Huizinga | Q77086497 | ||
Hanane el Bannoudi | Q114563694 | ||
P2093 | author name string | Jun Wang | |
Thomas Häupl | |||
André M Deelder | |||
P2860 | cites work | Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity | Q30835165 |
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. | Q38317804 | ||
Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. | Q42169367 | ||
P433 | issue | 6 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 1620-1629 | |
P577 | publication date | 2010-06-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid | |
P478 | volume | 62 |
Q38634916 | A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts |
Q41701035 | A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis. |
Q40513802 | A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease |
Q35939105 | Acute phase inflammation is characterized by rapid changes in plasma/peritoneal fluid N-glycosylation in mice |
Q39146323 | Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint |
Q48138068 | Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy. |
Q36125875 | Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy |
Q58234756 | Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis |
Q37311301 | Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies |
Q64122268 | Antibody-dependent and -independent mechanisms of inflammatory arthritis |
Q41762205 | Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies |
Q37693939 | Autoantibodies to posttranslational modifications in rheumatoid arthritis |
Q38177181 | Autoantibody-mediated bone loss |
Q37492376 | Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis |
Q39361224 | Cellular and molecular pathways of structural damage in rheumatoid arthritis |
Q35878770 | Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination |
Q36577396 | Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
Q58572572 | Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential |
Q55050150 | Complement in the Initiation and Evolution of Rheumatoid Arthritis. |
Q33420853 | Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity |
Q57676590 | Coupling porous sheathless interface MS with transient-ITP in neutral capillaries for improved sensitivity in glycopeptide analysis |
Q50210105 | Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications |
Q47804590 | Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? |
Q34568233 | Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages |
Q34994340 | Fc-glycosylation of IgG1 is modulated by B-cell stimuli |
Q38615357 | Fcγ receptor pathways during active and passive immunization |
Q38388421 | Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses |
Q42069958 | Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis |
Q39295277 | Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis |
Q26782025 | Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review |
Q35003989 | Glycomic signatures on serum IgGs for prediction of postvaccination response |
Q36742404 | Glycoproteomic analysis of antibodies |
Q35311994 | Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss |
Q92106772 | How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis |
Q36245665 | Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis |
Q92027568 | IgE Glycosylation in Health and Disease |
Q38631840 | IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis. |
Q28545233 | IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence |
Q40108236 | IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice. |
Q43420843 | IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies. |
Q88650321 | Immunological responses to influenza vaccination: lessons for improving vaccine efficacy |
Q34604615 | Insights from populations at risk for the future development of classified rheumatoid arthritis |
Q36959840 | Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. |
Q38787980 | Label-free detection of immune complexes with myeloid cells. |
Q45924953 | Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. |
Q36157114 | Microscale purification of antigen-specific antibodies |
Q51740730 | Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation. |
Q36195303 | Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation |
Q50497045 | Nanoscale reversed-phase liquid chromatography-mass spectrometry of permethylated N-glycans. |
Q52608527 | Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases. |
Q60301434 | Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies |
Q35873009 | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid |
Q91844287 | Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential |
Q26752274 | Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs) |
Q38957490 | Regulation of antibody effector functions through IgG Fc N-glycosylation |
Q39251627 | Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease |
Q47700104 | Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation. |
Q57253408 | Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')₂ versus Fc sialylation |
Q55347406 | Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis. |
Q36768842 | Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. |
Q36221190 | Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans |
Q38239288 | Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G. |
Q38851112 | Sweet but dangerous - the role of immunoglobulin G glycosylation in autoimmunity and inflammation. |
Q37123859 | T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. |
Q58746430 | Tertiary Lymphoid Structures: Autoimmunity Goes Local |
Q50129712 | The B cell response to citrullinated antigens in the development of rheumatoid arthritis. |
Q60047547 | The Clinical Value of Autoantibodies in Rheumatoid Arthritis |
Q47331159 | The Role of Autoantibodies in Bone Metabolism and Bone Loss |
Q38117686 | The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies |
Q38161557 | The case for measuring antibodies to specific citrullinated antigens. |
Q37980340 | The influence of ACPA status and characteristics on the course of RA. |
Q38206946 | The pathogenic potential of autoreactive antibodies in rheumatoid arthritis. |
Q26862195 | The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection |
Q50308665 | The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis |
Q38815526 | The role of autoantibodies in the pathophysiology of rheumatoid arthritis |
Q37995919 | The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. |
Q61452098 | The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis |
Q38232105 | Type I and type II Fc receptors regulate innate and adaptive immunity |
Q52728264 | Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection. |
Q53057615 | [Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis]. |
Q85397964 | [Glycosylation-dependent effector function of IgG antibodies] |
Search more.